Approach: The multi-stage methodology includes literature review, virtual focus groups with 12 operators and 12 residents each, measure development with subject matter experts, quantitative validation surveying 145 operators and 250 recovery house residents, and psychometric analysis using exploratory and confirmatory factor analysis.

Innovations: This project created the first comprehensive, validated measures of intervention stigma and MOUD capacity specifically for recovery housing settings, capturing stigma across three FDA-approved MOUD forms and two administration routes. The validated measures will enable researchers and operators alike to assess MOUD-related barriers, advancing evidence-based policy development and future recovery housing research.

Watch an interview with Rachel to learn more.

Presentations and Publications:

Winograd, R. P. (2024). We could, couldn’t we? Measuring attitudinal and capacity barriers to supporting residents on MOUD in recovery housing. Presentation at the National Conference on Addiction Recovery Science (NCARS).

Winograd, R. P. (2024). Developing a Measure of MOUD Barriers in Recovery Housing: Findings from the MO-ISTARR project. I-STARR Webinar.

Winograd, R. P. (2024). We could, couldn’t we? Measuring attitudinal and capacity barriers to supporting residents on MOUD in recovery housing. Presentation at the annual AMERSA Conference.

Park, B., Winograd, R. P., Ghonasgi, R., Nellis, M., Smith, D., & Mericle, A. A. (2025). MOUD Stigma Distinguished by Medication-Specific Lived Experience Among Recovery Housing Residents. Poster at the annual Collaborative Perspectives on Addiction (CPA) conference.

Park, B., Winograd, R. P., Ghonasgi, R., Nellis, M., Smith, D., & Mericle, A. A. (2025). Evaluating Attitudes Toward Medications for Opioid Use Disorder (MOUD) Among Recovery Housing Residents by Lived Experience With MOUD, Racial-Ethnic Identity, and Gender. Poster at the annual College on Problems of Drug Dependence (CPDD) conference.